Related Experiment Video
Updated: Jun 10, 2025

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
TEAD transcription factor family emerges as a promising therapeutic target for oral squamous cell carcinoma
Shuang Wang1,2, Dan Shao3, Xiaoyan Gao4
1Department of Stomatology, Qingdao West Coast New District Central Hospital, Qingdao, China.
Abstract:
The treatment of oral squamous cell carcinoma (OSCC) remains a significant difficulty, as there has been no improvement in survival rates over the past fifty years. Hence, exploration and confirmation of new dependable treatment targets and biomarkers is imperative for OSCC therapy. TEAD transcription factors are crucial for integrating and coordinating multiple signaling pathways that are essential for embryonic development, organ formation, and tissue homeostasis. In addition, by attaching to coactivators, TEAD modifies the expression of genes such as Cyr61, Myc, and connective tissue growth factor, hence facilitating tumor progression. Therefore, TEAD is regarded as an effective predictive biomarker due to its significant connection with clinical parameters in several malignant tumors, including OSCC. The efficacy of existing drugs that specifically target TEAD has demonstrated encouraging outcomes, indicating its potential as an optimal target for OSCC treatment. This review provides an overview of current targeted therapy strategies for OSCC by highlighting the transcription mechanism and involvement of TEAD in oncogenic signaling pathways. Finally, the feasibility of utilizing TEAD as an innovative approach to address OSCC and its potential clinical applications were analyzed and discussed.
Insights
Targeting TEAD transcription factors offers a promising new strategy for oral squamous cell carcinoma (OSCC) treatment. Research highlights TEAD
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Oral squamous cell carcinoma (OSCC) treatment has seen no survival rate improvement in 50 years, necessitating novel therapeutic targets.
- TEAD transcription factors are vital in development and homeostasis, but also promote tumor progression by regulating genes like Cyr61 and Myc.
- TEAD's association with clinical parameters in various cancers, including OSCC, establishes it as a potential predictive biomarker.
Purpose of the Study:
- To review current targeted therapy strategies for OSCC.
- To elucidate the role of TEAD transcription factors in OSCC oncogenic signaling pathways.
- To analyze the potential of TEAD as an innovative therapeutic target and biomarker for OSCC.
Main Methods:
- Literature review of TEAD transcription factors' role in OSCC.
- Analysis of TEAD's involvement in oncogenic signaling pathways.
- Evaluation of existing TEAD-targeting drugs and their efficacy.
Main Results:
- TEAD transcription factors are implicated in OSCC progression through gene regulation.
- TEAD is a significant biomarker correlating with clinical parameters in OSCC.
- Existing TEAD-targeting drugs show encouraging results, suggesting TEAD's therapeutic potential.
Conclusions:
- TEAD transcription factors represent a viable and innovative therapeutic target for OSCC.
- Targeting TEAD offers a promising avenue for improving OSCC treatment outcomes.
- Further clinical applications of TEAD-based therapies for OSCC warrant investigation.
More Related Videos
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Master Transcription Regulators
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
General Transcription Factors
Transcription Factors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...